![John E. Lucas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of John E. Lucas
Former positions of John E. Lucas
Companies | Position | Start | End |
---|---|---|---|
THOMAS PHARMACEUTICALS LTD | Director/Board Member | 2008-04-27 | 2008-04-27 |
Director of Finance/CFO | 2008-04-27 | 2008-04-27 | |
President | - | 2008-04-27 | |
SEQUENOM, INC. | Director/Board Member | 2006-01-01 | 2006-01-01 |
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Chairman | 1998-12-31 | - |
President | 1998-12-31 | - |
Statistics
International
United States | 4 |
Operational
Director/Board Member | 2 |
President | 2 |
Chairman | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
Sequenom, Inc.
![]() Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Thomas Pharmaceuticals Ltd.
![]() Thomas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Thomas Pharmaceuticals Ltd. is engaged in the provision of services in the health care industry. The company was founded on May 19, 2005 and is headquartered in Matawan, NJ. | Health Technology |
- Stock Market
- Insiders
- John E. Lucas
- Experience